Icon Cancer Centre Singapore receives three years’ accreditation

In its second round of assessment by Australian Council on Healthcare Standards International (ACHSI), Icon Cancer Centre Singapore has again successfully achieved EQuiP* accreditation with outstanding results. Icon Singapore are the only oncology provider in Singapore to receive ACHSI accreditation.

In 2020, Icon Cancer Centre Singapore was the first oncology centre in Asia to achieve ACHSI accreditation signifying a commitment to patient quality and safety through a global network.

ACHSI accreditation is a leading and trusted healthcare quality improvement partner who provide organisations with international recognition and benchmark performance and outcomes to industry standards.

Group Manager Clinical Governance & Quality, Catherine Di Stasi said this international accreditation recognises a commitment to safety.

“Icon has robust governance structures and policies and procedures across all regions which benefit global communities and ensure safety is first and foremost,” said Catherine.

“The results of this assessment reflect an ongoing commitment by our teams and doctors to uphold the quality of our care and the safety of our patients and is a joint effort by our international team.”

Icon CEO – ASEAN and Hong Kong, Serena Wee said this has been a team effort. “The Singapore team go above and beyond to ensure the safety of our patients, and it’s great to see us continue to improve and uphold best practice for quality care,” said Serena.

*The Evaluation and Quality Improvement Program (EQuIP) is a quality assessment and improvement program for healthcare organisations that support excellence in patient care and services, and continuous quality improvement. EQuIP standards are rigorously developed and accredited by the ISQua External Evaluation Association (IEEA).